Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137


Hemolytic-uremic syndrome in a grandmother.

Crawford LC, Crawford ML, Moore SR.

Emerg Infect Dis. 2010 Nov;16(11):1792-5. doi: 10.3201/eid1611.091464. No abstract available.


Hemolytic uremic syndrome following infection with O111 Shiga toxin-producing Escherichia coli revealed through molecular diagnostics.

Operario DJ, Moonah S, Houpt E.

J Clin Microbiol. 2014 Mar;52(3):1003-5. doi: 10.1128/JCM.02855-13. Epub 2013 Dec 26.


Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli.

Fasel D, Mellmann A, Cernela N, Hächler H, Fruth A, Khanna N, Egli A, Beckmann C, Hirsch HH, Goldenberger D, Stephan R.

J Clin Microbiol. 2014 Apr;52(4):1301-3. doi: 10.1128/JCM.03459-13. Epub 2014 Feb 5.


Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome.

Buvens G, De Rauw K, Roisin S, Vanfraechem G, Denis O, Jacobs F, Scheutz F, Piérard D.

J Clin Microbiol. 2013 May;51(5):1633-5. doi: 10.1128/JCM.03025-12. Epub 2013 Mar 6.


The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.

Byrne L, Jenkins C, Launders N, Elson R, Adak GK.

Epidemiol Infect. 2015 Dec;143(16):3475-87. doi: 10.1017/S0950268815000746. Epub 2015 Apr 29.


[Listen to mom].

Cofre G J.

Rev Chilena Infectol. 2008 Dec;25(6):445. doi: /S0716-10182008000600004. Epub 2009 Jan 29. Spanish. No abstract available.


Rapid culture-free identification and molecular typing of Shiga toxin-producing Escherichia coli by PCR-RFLP.

Shima K, Kawamura N, Hinenoya A, Sugimoto N, Wu Y, Asakura M, Nishimura K, Nair GB, Yamasaki S.

Microbiol Immunol. 2008 Jun;52(6):310-3. doi: 10.1111/j.1348-0421.2008.00038.x.


Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.

Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, White PL, Wymore K, Gierke RE, Mahon BE, Griffin PM; Emerging Infections Program Foodnet Working Group.

Foodborne Pathog Dis. 2013 May;10(5):453-60. doi: 10.1089/fpd.2012.1401. Epub 2013 Apr 6.


The German Escherichia coli outbreak--could it happen here?

Kirk MD.

Med J Aust. 2011 Sep 19;195(6):325-6. No abstract available.


Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.

Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, de Valk H.

Pediatr Infect Dis J. 2008 Jul;27(7):595-601. doi: 10.1097/INF.0b013e31816a062f.


Rare E. coli strain races through Europe; high rate of kidney failure reported.

Voelker R.

JAMA. 2011 Jul 6;306(1):29. doi: 10.1001/jama.2011.889. No abstract available.


Undercooked ground beef and person-to-person transmission as major risk factors for sporadic hemolytic uremic syndrome related to Shiga-toxin producing Escherchia coli infections in children in France.

Vaillant V, Espié E, de Valk H, Durr U, Barataud D, Bouvet P, Grimont F, Desenclos JC.

Pediatr Infect Dis J. 2009 Jul;28(7):650-3. doi: 10.1097/INF.0b013e3181993731.


Hemolytic uremic syndrome associated with Escherichia coli O8:H19 and Shiga toxin 2f gene.

Friesema IH, Keijzer-Veen MG, Koppejan M, Schipper HS, van Griethuysen AJ, Heck ME, van Pelt W.

Emerg Infect Dis. 2015 Jan;21(1):168-9. doi: 10.3201/eid2101.140515. No abstract available.


An epidemiological and environmental study of Shiga toxin-producing Escherichia coli in India.

Kumar A, Taneja N, Sharma M.

Foodborne Pathog Dis. 2014 Jun;11(6):439-46. doi: 10.1089/fpd.2013.1613. Epub 2014 May 5.


Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany.

Werber D, Beutin L, Pichner R, Stark K, Fruth A.

Emerg Infect Dis. 2008 Nov;14(11):1803-6. doi: 10.3201/eid1411.080361.


Public Health Microbiology of Shiga Toxin-Producing Escherichia coli.

Caprioli A, Scavia G, Morabito S.

Microbiol Spectr. 2014 Dec;2(6). doi: 10.1128/microbiolspec.EHEC-0014-2013. Review.


Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.

Karpman D.

Nephrol Dial Transplant. 2012 Oct;27(10):3669-74. doi: 10.1093/ndt/gfs456. No abstract available.


Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011.

Altmann M, Spode A, Altmann D, Wadl M, Benzler J, Eckmanns T, Krause G, An der Heiden M.

Emerg Infect Dis. 2011 Oct;17(10):1906-9. doi: 10.3201/eid1710.111027.


Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011.

Askar M, Faber MS, Frank C, Bernard H, Gilsdorf A, Fruth A, Prager R, Hohle M, Suess T, Wadl M, Krause G, Stark K, Werber D.

Euro Surveill. 2011 Jun 2;16(22). pii: 19883. No abstract available.

Supplemental Content

Support Center